The increasing importance for dedicated products including cleanroom control products and other materials used inside the cleanroom facilities to avoid contamination has opened up a huge market for these products .

Since the fight to combat contamination control is not likely not end in the near future, the demand for cleanroom consumables will continue to steadily increase as we continue to make technological as well as social advancements.

There are a number of industries today that rely on the benefits of cleanroom consumables in order to operate efficiently and effectively while simultaneously reducing the risk of hazardous issues throughout unique projects and procedures. From the electronics industry to the automotive industry to medical manufacturing and many others, cleanroom consumables have contributed to the success of many products spanning a vast range of critical environments.

The medical manufacturing industry finds tremendous value in the investment of cleanroom consumables. Perhaps the most necessary application of cleanroom consumables, the medical manufacturing industry leverages the benefits of wipers, facemasks and glove liners, among many other products, in order to develop state-of-the-art drug delivery systems, heart valves, catheters, and pacemakers as well as a plethora of other biomedical devices. Without cleanroom consumables, such life-saving devices would be at risk for high levels of contamination. High levels of contamination could result in serious repercussions and consequences for both manufacturers and patients.

In its new forecast, the McIlvaine Company has predicted that the revenues derived from sales of consumable products to cleanrooms will rise worldwide from $6 billion this year to over $8 billion in 2015.While the largest purchasing industry will be the semiconductor industry, it will be followed by memory storage, pharmaceutical and biotechnology facilities, it points out. As per the study, Asian countries will be the largest purchasers in 2015.

Indian pharma majors with high export profiles are increasingly turning to highly sophisticated cleanroom products to remain in the highly competitive global pharmaceutical market as drug regulators in the US and European Union are tightening the regulatory and monitoring systems to filter out low quality products from their markets

According to an expert,the current cleanroom practices in many of the firms are not up to the right standards. But, with the regulators of the western markets getting stricter, the Indian exporters cannot afford to take risk on cleanroom products. More and companies are looking for the cleanroom products which adheres to the standards of the destination country.

Kitten Enterprises, for instance, which has almost 500 products dedicated to the pharma sector out of a total of 700 products marketed in the country, has tied up with European and US firms to import and market more than 300 cleanroom solutions and related materials.

The company has recently launched three more products with primary usage for pharma cleanroom facilities - a hygene control product for cleaning equipments and surfaces, a washroom control product with European quality standards and an advanced microbial sampler to clean air in the controlled area. Earlier, it had launched paper, pen, footwear and other tools to be used only in cleanrooms, to avoid contamination.

It has also plans to launch specially designed telephone, vacuum cleaner and chair dedicated to use inside cleanrooms in pharmaceutical facilities, imported from the western market. "Market for these types of products are very huge in the western market. In India, it is just a novel area. Many a time the price for these products are much higher than the ordinary products available in our market and this made the companies to stick on to such products. Now the situation is changing and many who had laughed at the idea at first are now realising the importance of these products," says a spokesperson of the company. However, the market for such products is still in a nascent stage in India and cannot be quantified at present, he added.